ITM2B Polyclonal Antibody

Amyloid precursor proteins are processed by beta-secretase and gamma-secretase to produce beta-amyloid peptides which form the characteristic plaques of Alzheimer disease. This gene encodes a transmembrane protein which is processed at the C-terminus by furin or furin-like proteases to produce a small secreted peptide which inhibits the deposition of beta-amyloid. Mutations which result in extension of the C-terminal end of the encoded protein, thereby increasing the size of the secreted peptide, are associated with two neurogenerative diseases, familial British dementia and familial Danish dementia.

ABRI, ABri/ADan amyloid peptide, BRI 2, BRI, BRI2, BRICD 2B, BRICD2B, BRICHOS domain containing 2B, E25B, E3 16, E3-16, FBD, imBRI2, Immature BRI2, Integral membrane protein 2B, ITM 2B, ITM2B, ITM2B, Protein E25B, RDGCA, Transmembrane protein BRI